自身免疫性疱病与银屑病的相关性

doi:10.35541/cjd.20200162

中华皮肤科杂志 ›› 2022, Vol. 55 ›› Issue (5): 452-455.doi: 10.35541/cjd.20200162

自身免疫性疱病与银屑病的相关性

闪莹^1，2 左亚刚¹

¹中国医学科学院、北京协和医学院北京协和医院皮肤科协和医学转化中心国家皮肤与免疫疾病临床医学研究中心，北京 100730；²河北北方学院，张家口 075000

收稿日期:2020-02-24 修回日期:2020-07-30 发布日期:2022-04-29
通讯作者: 左亚刚 E-mail:zuoyagang@263.net
基金资助:
国家自然科学基金（81972944）；北京市自然科学基金（7192166）

Correlation between autoimmune bullous diseases and psoriasis

Shan Ying^1,2, Zuo Yagang¹

¹Department of Dermatology, National Clinical Research Center for Skin and Immune Diseases, Translational Medicine Center of Peking Union Medical College Hospital, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China; ²Department of Dermatology, Graduate School of Hebei North University, Zhangjiakou 075000, Hebei, China

Received:2020-02-24 Revised:2020-07-30 Published:2022-04-29
Contact: Zuo Yagang E-mail:zuoyagang@263.net
Supported by:
National Natural Science Foundation of China（81972944）; Natural Science Foundation of Beijing Municipality （7192166）

摘要/Abstract

摘要： 【摘要】自身免疫性疱病（AIBD）和银屑病的发病机制有部分相似性。近年来，多项研究报道银屑病与AIBD之间具有相关性，以大疱性类天疱疮多见，还包括寻常型天疱疮、红斑型天疱疮、线状IgA大疱性皮病等，多数AIBD在银屑病发病后发生，部分患者两病同时出现或AIBD先出现。本文综述AIBD与银屑病发病的相关性及可能存在的机制。

关键词: 银屑病, 皮肤疾病, 水疱大疱性, 自身免疫疾病, 天疱疮, 类天疱疮, 大疱性

Abstract: 【Abstract】 There are overlaps in pathogenesis between autoimmune bullous diseases （AIBDs） and psoriasis. In recent years, there have been many reports on correlations between psoriasis and AIBDs. Bullous pemphigoid is the most common AIBD associated with psoriasis, followed by pemphigus vulgaris, pemphigus erythematosus and linear IgA bullous dermatosis. AIBDs occur after the onset of psoriasis in most cases, but simultaneously with or before the onset of psoriasis in some patients. This review summarizes correlations between AIBDs and psoriasis, as well as possible mechanisms.

Key words: Psoriasis, Skin diseases, vesiculobullous, Autoimmune diseases, Pemphigus, Pemphigoid, Bullous

闪莹左亚刚. 自身免疫性疱病与银屑病的相关性[J]. 中华皮肤科杂志, 2022,55(5):452-455. doi:10.35541/cjd.20200162

Shan Ying, Zuo Yagang. Correlation between autoimmune bullous diseases and psoriasis[J]. Chinese Journal of Dermatology, 2022, 55(5): 452-455.doi:10.35541/cjd.20200162

参考文献 35

［1］	Kridin K, Kridin M, Shalom G, et al. The coexistence of pemphigus and psoriasis: a systematic review and meta⁃analysis［J］. Immunol Res, 2019,67（1）:134⁃141. doi: 10.1007/s12026⁃018⁃9031⁃6.
［2］	Ho YH, Hu HY, Chang YT, et al. Psoriasis is associated with increased risk of bullous pemphigoid: a nationwide population⁃based cohort study in Taiwan［J］. J Dermatol, 2019,46（7）:604⁃609. doi: 10.1111/1346⁃8138.14902.
［3］	Kridin K, Zelber⁃Sagi S, Comaneshter D, et al. Association between pemphigus and psoriasis: a population⁃based large⁃scale study［J］. J Am Acad Dermatol, 2017,77（6）:1174⁃1175. doi: 10.1016/j.jaad.2017.07.007.
［4］	Phan K, Goyal S, Murrell DF. Association between bullous pemphigoid and psoriasis: systematic review and meta⁃analysis of case⁃control studies［J］. Australas J Dermatol, 2019,60（1）:23⁃28. doi: 10.1111/ajd.12899.
［5］	Wilczek A, Sticherling M. Concomitant psoriasis and bullous pemphigoid: coincidence or pathogenic relationship?［J］. Int J Dermatol, 2006,45（11）:1353⁃1357. doi: 10.1111/j.1365⁃4632. 2006.02861.x.
［6］	Ohata C, Ishii N, Koga H, et al. Coexistence of autoimmune bullous diseases （AIBDs） and psoriasis: a series of 145 cases［J］. J Am Acad Dermatol, 2015,73（1）:50⁃55. doi: 10.1016/j.jaad.2015.03.016.
［7］	Zhang X, Mao X, Theresia C, et al. Pemphigus associated with psoriasis vulgaris: a retrospective study of seven patients and a review of the literature［J］. Acta Dermatovenerol Croat, 2018,26（3）:226⁃232.
［8］	Kridin K, Ahmed AR. Anti⁃p200 Pemphigoid: a systematic review［J］. Front Immunol, 2019,10:2466. doi: 10.3389/fimmu.2019. 02466.
［9］	Zheng J, Liu N, Wang Y, et al. Pemphigus vulgaris with psoriasis vulgaris successfully treated with methotrexate and low⁃dose methylprednisolone［J］. Dermatol Ther, 2020,33（1）:e13165. doi: 10.1111/dth.13165.
［10］	Tsuchida Y, Hayashi R, Ansai O, et al. Generalized pustular psoriasis complicated with bullous pemphigoid［J］. Int J Dermatol, 2019,58（3）:e66⁃e67. doi: 10.1111/ijd.14332.
［11］	Claus S, Ziemer M, Simon JC, et al. Coincidence of annular pustular psoriasis, pemphigus foliaceus, and leukocytoclastic vasculitis associated with chronic cholecystitis［J］. J Dtsch Dermatol Ges, 2016,14（8）:830⁃831. doi: 10.1111/ddg.12619.
［12］	Fujimura Y, Natsuga K, Hamade Y, et al. Anti⁃laminin⁃gamma 1 pemphigoid with generalized pustular psoriasis and psoriasis vulgaris［J］. Acta Derm Venereol, 2016,96（1）:120⁃121. doi: 10. 2340/00015555⁃2168.
［13］	Nin M, Tokunaga D, Ishii N, et al. Case of coexisting psoriatic arthritis and bullous pemphigoid improved by etanercept［J］. J Dermatol, 2013,40（1）:55⁃56. doi: 10.1111/j.1346⁃8138.2012. 01659.x.
［14］	Furue K, Ito T, Tsuji G, et al. Autoimmunity and autoimmune co⁃morbidities in psoriasis［J］. Immunology, 2018,154（1）:21⁃27. doi: 10.1111/imm.12891.
［15］	Becker JG, Mundi JP, Newlove T, et al. Development of linear IgA bullous dermatosis in a patient with psoriasis taking ustekinumab［J］. J Am Acad Dermatol, 2012,67（4）:e150⁃e151. doi: 10.1016/j.jaad.2011.11.955.
［16］	Fujimoto N, Matsuo S, Satoh T. Psoriasis vulgaris in a patient with pemphigus vulgaris on corticosteroid therapy［J］. J Dtsch Dermatol Ges, 2018,16（5）:606⁃608. doi: 10.1111/ddg.13505.
［17］	Dainichi T, Kabashima K. Interaction of psoriasis and bullous diseases［J］. Front Med （Lausanne）, 2018,5:222. doi: 10.3389/fmed.2018.00222.
［18］	Rosmaninho A, Oliveira A, Sanches M, et al. IgA pemphigus and pustular psoriasis: a possible relation［J］. Eur J Dermatol, 2011,21（1）:100⁃101. doi: 10.1684/ejd.2011.1159.
［19］	Ohashi M, Takagi H, Mizutani Y, et al. Bullous pemphigoid with IgG autoantibodies to the α3 subunit of laminin 332 associated with psoriasis vulgaris［J］. Eur J Dermatol, 2017,27（3）:306⁃307. doi: 10.1684/ejd.2017.2980.
［20］	Natsumi A, Sugawara K, Yasumizu M, et al. Re⁃investigating the basement membrane zone of psoriatic epidermal lesions: is laminin⁃511 a new player in psoriasis pathogenesis?［J］. J Histochem Cytochem, 2018,66（12）:847⁃862. doi: 10.1369/002 2155418782693.
［21］	Minakawa S, Matsuzaki Y, Hashimoto T, et al. Dipeptidyl peptidase⁃4 inhibitor⁃associated anti⁃laminin⁃γ1 （p200） pemphigoid in a patient with psoriasis vulgaris［J］. J Dermatol, 2020,47（1）:e25⁃e26. doi: 10.1111/1346⁃8138.15126.
［22］	Maglie R, Hertl M. Pharmacological advances in pemphigoid［J］. Curr Opin Pharmacol, 2019,46:34⁃43. doi: 10.1016/j.coph.2018. 12.007.
［23］	Yasukawa S, Dainichi T, Kokuba H, et al. Bullous pemphigoid followed by pustular psoriasis showing Th1, Th2, Treg and Th17 immunological changes［J］. Eur J Dermatol, 2009,19（1）:69⁃71. doi: 10.1684/ejd.2008.0572.
［24］	Pezzolo E, Naldi L. Epidemiology of major chronic inflammatory immune⁃related skin diseases in 2019［J］. Expert Rev Clin Immunol, 2020,16（2）:155⁃166. doi: 10.1080/1744666X.2020. 1719833.
［25］	Hirata J, Hirota T, Ozeki T, et al. Variants at HLA⁃A, HLA⁃C, and HLA⁃DQB1 confer risk of psoriasis vulgaris in Japanese［J］. J Invest Dermatol, 2018,138（3）:542⁃548. doi: 10.1016/j.jid.2017.10.001.
［26］	Vázquez⁃Osorio I, González⁃Delgado S, Suárez⁃García C, et al. Blisters induced by PUVA: a report of 5 cases［J］. Actas Dermosifiliogr, 2018,109（8）:e11⁃e16. doi: 10.1016/j.ad.2017. 10. 011.
［27］	Miyamoto D, Santi CG, Aoki V, et al. Bullous pemphigoid［J］. An Bras Dermatol, 2019,94（2）:133⁃146. doi: 10.1590/abd1806⁃4841.20199007.
［28］	Wilmer EN, Becker N, Chen A, et al. Etanercept⁃induced generalization of chronic, localized, anogenital bullous pemphigoid in a psoriatic patient［J］. JAAD Case Rep, 2016,2（1）:25⁃27. doi: 10.1016/j.jdcr.2015.12.006.
［29］	Verheyden MJ, Bilgic A, Murrell DF. A systematic review of drug⁃induced pemphigoid［J］. Acta Derm Venereol, 2020. doi: 10.2340/00015555⁃3457.
［30］	Ho PH, Tsai TF. Development of bullous pemphigoid during secukinumab treatment for psoriasis［J］. J Dermatol, 2017,44（9）:e220⁃e221. doi: 10.1111/1346⁃8138.13909.
［31］	Onsun N, Sallahoglu K, Dizman D, et al. Bullous pemphigoid during ustekinumab therapy in a psoriatic patient［J］. Eur J Dermatol, 2017,27（1）:81⁃82. doi: 10.1684/ejd.2016.2888.
［32］	Kamata M, Asano Y, Shida R, et al. Secukinumab decreased circulating anti⁃BP180⁃NC16a autoantibodies in a patient with coexisting psoriasis vulgaris and bullous pemphigoid［J］. J Dermatol, 2019,46（6）:e216⁃e217. doi: 10.1111/1346⁃8138.14760.
［33］	Waki Y, Kamiya K, Komine M, et al. A case of anti⁃laminin γ1 （p200） pemphigoid with psoriasis vulgaris successfully treated with apremilast［J］. Eur J Dermatol, 2018,28（3）:413⁃414. doi: 10.1684/ejd.2018.3280.
［34］	Balighi K, Daneshpazhooh M, Mahmoudi H, et al. Switching from pemphigus vulgaris to psoriasis: a rare report of three cases［J］. Int J Dermatol, 2020,59（5）:e144⁃e146. doi: 10.1111/ijd. 14823.
［35］	Daulat S, Detweiler JG, Pandya AG. Development of pemphigus vulgaris in a patient with psoriasis treated with etanercept［J］. J Eur Acad Dermatol Venereol, 2009,23（4）:483⁃484. doi: 10.1111/ j.1468⁃3083.2008.02929.x.

[1]	孙玉姣王建波段紫钰窦进法李彦李建国张守民. 泛发性家族性良性慢性天疱疮1家系ATP2C1基因变异检测[J]. 中华皮肤科杂志, 2023, 0(3): 20210927-e20210927.
[2]	阮诗钒张鹏林婷婷罗仁炜鲍思怡薛晨瑶童泽群张亮亮龚婷纪超. 寻常型银屑病与血脂异常的相关性研究[J]. 中华皮肤科杂志, 2023, 0(3): 20220322-e20220322.
[3]	中华医学会皮肤性病学分会银屑病专业委员会. 银屑病生物制剂达标治疗专家共识[J]. 中华皮肤科杂志, 2023, 56(3): 191-203.
[4]	周健俞晨王刚. 司库奇尤单抗治疗13例难治性局限性脓疱型银屑病的临床疗效与安全性观察[J]. 中华皮肤科杂志, 2023, 56(3): 247-251.
[5]	胡琨杨晶王巧林陈军臣张谧朱武张斌窦冠珅 Wendong Chen, 匡叶红. [开放获取] 依奇珠单抗治疗银屑病短期疗效的单中心病例回顾性研究[J]. 中华皮肤科杂志, 2023, 56(3): 210-215.
[6]	万立胡彬罗红玉方美珍韩丽娟陈强周小勇陈柳青陈金波. 天疱疮或大疱性类天疱疮合并单纯疱疹病毒感染8例临床特征及治疗分析[J]. 中华皮肤科杂志, 2023, 56(3): 229-233.
[7]	何谐栗玉珍. 靶向JAK-STAT信号通路治疗银屑病的研究进展[J]. 中华皮肤科杂志, 2023, 56(3): 273-278.
[8]	杨琦郑捷. 生物制剂治疗对银屑病相关心血管疾病的影响[J]. 中华皮肤科杂志, 2023, 56(2): 165-169.
[9]	黄贺张学军. 白细胞介素23抑制剂古塞奇尤单抗在银屑病治疗中的应用[J]. 中华皮肤科杂志, 2023, 56(2): 181-184.
[10]	王召阳向欣陈云刘苗朝阳赵欣荣张振华刘元香马琳徐子刚. 生物制剂与甲氨蝶呤治疗儿童重度斑块状银屑病疗效及安全性比较[J]. 中华皮肤科杂志, 2023, 56(2): 112-117.
[11]	陈良宏孙艳王敬玉吴严. 本维莫德在皮肤病中的研究进展[J]. 中华皮肤科杂志, 2023, 0(2): 20210875-e20210875.
[12]	尹光文耿朦朦崔燕张守民李冬芹程秀永. 新生儿线状IgA大疱性皮病[J]. 中华皮肤科杂志, 2023, 56(2): 146-148.
[13]	曹淼崇杉王明悦. 不同浸浴方案对天疱疮患者皮损愈合的影响分析[J]. 中华皮肤科杂志, 2023, 56(1): 49-53.
[14]	杨莹郭青侯素春闵雪田佳彬乔朱卉林佳琳王小飞乌兰图雅张振颖李正风王彬刘晓明. 【开放获取】接受生物制剂治疗的银屑病患者COVID-19疫苗接种情况及对原发病影响的单中心横断面研究[J]. 中华皮肤科杂志, 2023, 56(1): 59-63.
[15]	郑佳媛余炳前陈显侠骆志成. 成人寻常型银屑病瘙痒特征及对生活质量的影响调查[J]. 中华皮肤科杂志, 2022, 55(9): 790-794.

自身免疫性疱病与银屑病的相关性

Correlation between autoimmune bullous diseases and psoriasis

PDF

PDF (Mobile)

可视化

摘要/Abstract

引用本文

使用本文

参考文献 35

相关文章 15

Metrics

本文评价

推荐阅读 10